Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.

Site Map

Site Map of http://www.researchandmarkets.com


Site Map
Pharmaceuticals and Healthcare
   Pharmaceuticals 1 (Latest Titles)
   Pharmaceuticals 2
   Pharmaceuticals 3
   Pharmaceuticals 4

      Cardiovascular  << You are in This Category




#  A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  


#

2000 Cardiovascular Market Review: Bringing the Cardiovascular Market Together static version printer friendly pdf version
2007 Essentials of the US Hospital IT Market - Cardiology PACS Chapter static version printer friendly pdf version


^ Top



A

A Nurses Guide to Caring for Cardiac Intervention Patients static version printer friendly pdf version
Abdominal Aortic Aneurysm Treatment: A Panel Discussion among Eight Vascular Surgeons static version printer friendly pdf version
Advances in Coronary Angioplasty: Drug Eluting Stents static version printer friendly pdf version
AIIRBS: Benefits Beyond Blood Pressure: Seeking Indications Throughout The Cardiovascular Continuum static version printer friendly pdf version
Angiogenesis Modulators static version printer friendly pdf version
Anti-hypertensives: Patent Defense Strategies - Combating Generic Competition Through Lifecycle Management static version printer friendly pdf version
Antidyslipidemics - The Power Of Two static version printer friendly pdf version
Antithrombotics in Acute Ischemic Stroke - The Clot Thickens static version printer friendly pdf version
Arrhythmia Update 2000: Developments in Drugs Versus Devices static version printer friendly pdf version


^ Top



C

Cardiac Marker Diagnostic Testing Markets static version printer friendly pdf version
Cardiac Markers - Making their Mark on the Medicines Market  static version printer friendly pdf version
Cardiac Pacing and ICDs, 5th Edition static version printer friendly pdf version
Cardiac Rhythm Management Devices World Markets static version printer friendly pdf version
Cardiology - Acute Coronary Syndrome, Anticoagulants static version printer friendly pdf version
Cardiology Drug Licensing Opportunities, 2002  static version printer friendly pdf version
Cardiology, Competitive Strategies, 2002  static version printer friendly pdf version
Cardiovascular and Circulatory System - Angina Drug Pipeline Report static version printer friendly pdf version
Cardiovascular and Circulatory System - Arrhythmiasis Drug Pipeline Report static version printer friendly pdf version
Cardiovascular and Circulatory System - Atherosclerosis or Coronary Artery Disease Drug Pipeline Report static version printer friendly pdf version
Cardiovascular and Circulatory System - Congestive Heart Failure Drug Pipeline Report static version printer friendly pdf version
Cardiovascular and Circulatory System - Edema Drug Pipeline Report static version printer friendly pdf version
Cardiovascular and Circulatory System - Hypercholesterolemia Drug Pipeline Report static version printer friendly pdf version
Cardiovascular and Circulatory System - Hypertension Drug Pipeline Report static version printer friendly pdf version
Cardiovascular and Circulatory System - Intermittent Claudication Drug Pipeline Report static version printer friendly pdf version
Cardiovascular and Circulatory System - Ischemia static version printer friendly pdf version
Cardiovascular and Circulatory System - Ischemia Drug Pipeline Report static version printer friendly pdf version
Cardiovascular and Circulatory System - Myocardial Infarction Drug Pipeline Report static version printer friendly pdf version
Cardiovascular and Circulatory System - Peripheral Vascular Disease Drug Pipeline Report static version printer friendly pdf version
Cardiovascular and Circulatory System - Stroke Drug Pipeline Report static version printer friendly pdf version
Cardiovascular and Circulatory System - Thrombosis Drug Pipeline Report static version printer friendly pdf version
Cardiovascular and Circulatory System Acute Coronary Syndromes  static version printer friendly pdf version
Cardiovascular and Circulatory System Angina  static version printer friendly pdf version
Cardiovascular and Circulatory System Arrhythmiasis  static version printer friendly pdf version
Cardiovascular and Circulatory System Atherosclerosis or Coronary Artery Disease  static version printer friendly pdf version
Cardiovascular and Circulatory System Congestive Heart Failure  static version printer friendly pdf version
Cardiovascular and Circulatory System Edema  static version printer friendly pdf version
Cardiovascular and Circulatory System Hypercholesterolemia  static version printer friendly pdf version
Cardiovascular and Circulatory System Hypertension  static version printer friendly pdf version
Cardiovascular and Circulatory System Intermittent Claudication  static version printer friendly pdf version
Cardiovascular and Circulatory System Myocardial Infarction  static version printer friendly pdf version
Cardiovascular and Circulatory System Peripheral Vascular Disease  static version printer friendly pdf version
Cardiovascular and Circulatory System Stroke  static version printer friendly pdf version
Cardiovascular and Circulatory System Thrombosis  static version printer friendly pdf version
Cardiovascular Disease Diagnostics - Global Strategic Business Report static version printer friendly pdf version
Cardiovascular Disease: Current Research, Devices and Drugs static version printer friendly pdf version
Cardiovascular Drug Delivery - Technologies, Markets and Companies static version printer friendly pdf version
Cardiovascular Drug Discoveries 2008 static version printer friendly pdf version
Cardiovascular Drug Reviews static version printer friendly pdf version
Cardiovascular Drug World Markets, 2003-2011 static version printer friendly pdf version
Cardiovascular Market Drugs and Devices Market: Successes and Cardiovascular Setbacks in the Third Quarter of 2005 static version printer friendly pdf version
Cardiovascular Therapy US Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles static version printer friendly pdf version
Cardiovascular Therapy Worldwide Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles static version printer friendly pdf version
Chinese Markets for Cardiovascular Drugs 2006 static version printer friendly pdf version
Chronic and Acute Heart Failure - Diversity and Disappointment static version printer friendly pdf version
Chronic Obstructive Pulmonary Disease (COPD) 2008 Edition static version printer friendly pdf version
Commercial Insight: Antidyslipidemics - Branded Statins Beware, Generics Are Amongst You static version printer friendly pdf version
Commercial Insight: Cardiovascular Market Overview - Raft of Patent Expires Threaten Blockbusters static version printer friendly pdf version
Competitor Analysis: Antihypertensives static version printer friendly pdf version
Competitor Analysis: Antithrombotics static version printer friendly pdf version
Competitor Analysis: Cholesterol Management static version printer friendly pdf version
Competitor Analysis: Thrombolytic Agents static version printer friendly pdf version
Congestive Heart Failure: Advances in Treatment and Their Potential Market static version printer friendly pdf version
Congestive Heart Failure: Opinion Leader Forum Expert's Views and Perspective on Diagnosis,Treatment, Product Performance and Closing the Need Gap  static version printer friendly pdf version


^ Top



D

Diabetes, Metabolic Syndrome and Cardiovascular Disease Markets static version printer friendly pdf version
Diabetic Cardiology static version printer friendly pdf version
Disease and Therapy Review: Chronic Obstructive Pulmonary Disease static version printer friendly pdf version
Disease and Therapy Review: Heart Failure static version printer friendly pdf version
Disease and Therapy Review: Hypertension static version printer friendly pdf version
Disease and Therapy Review: Myocardial Infaction static version printer friendly pdf version
Disease and Therapy Review: Stroke static version printer friendly pdf version
Drug Delivery Systems in Cardiovascular Therapeutics static version printer friendly pdf version
Drugs of Tomorrow 2001: Hypertension - The Mounting Pressures Facing New Compounds static version printer friendly pdf version
Drugs of Tomorrow 2002: Reperfusion Injury - The Next Breakthrough in Clinical Cardiology static version printer friendly pdf version
Drugs, Devices and Procedures of Tomorrow: Acute Stroke - Chasing the need for speed static version printer friendly pdf version
Dyslipidemia: Opportunities in Cardiovascular Risk Reduction static version printer friendly pdf version
Dyslipidemia: The Expanding Market for Statins and other Lipid Management Products static version printer friendly pdf version


^ Top



E

Emerging Technologies in Global Vascular Intervention: Peripheral Stenting static version printer friendly pdf version
Emerging Technologies in Heart Valves - European Marketplace static version printer friendly pdf version
Emerging Technologies in Replacement Heart Valves: US Marketplace static version printer friendly pdf version
Essential Hypertension and Its Causes: Neural and Non-Neural Mechanisms static version printer friendly pdf version
European Cardiovascular Drugs Markets static version printer friendly pdf version
European Markets for Arrhythmia Management Products, 2000-2011 static version printer friendly pdf version
European Stroke Therapy Markets static version printer friendly pdf version


^ Top



F

Functional Foods, Cardiovascular Disease and Diabetes static version printer friendly pdf version


^ Top



H

High-Density Lipoproteins: From Basic Biology to Clinical Aspects static version printer friendly pdf version
Hypertension Plus Heart Failure - Evaluation & Management Guidelines static version printer friendly pdf version


^ Top



I

Innovations in Cardiovascular Disease Management: Latest Surgical Procedures, Drugs and Medical Devices static version printer friendly pdf version
International (Non-US) Coronary Stent Dollar Volume by Region, 2000-2004 static version printer friendly pdf version


^ Top



K

Key Trends in European Patient Monitoring Systems Market static version printer friendly pdf version


^ Top



M

Manual of Surgical Treatment of Atrial Fibrillation static version printer friendly pdf version
Market Dynamics 2001: Anti-hypertensives - Aiirbs battle for supremacy static version printer friendly pdf version
Market Dynamics 2001: Anticoagulants - The Advent of a New Generation of Agents static version printer friendly pdf version
Market Dynamics 2001: Antiplatelets and Thrombolytics - Combination therapies key to market development static version printer friendly pdf version
Medications to Treat High Blood Cholesterol static version printer friendly pdf version


^ Top



N

Nuclear Cardiology Markets 2007 static version printer friendly pdf version


^ Top



O

Oxford Handbook of Cardiology, First Edition static version printer friendly pdf version


^ Top



P

Partneringdesk Deals and alliances in cardiovascular diseases static version printer friendly pdf version
Partneringreview 2006: Biopharma Deal Making By Therapy Area - Cardiovascular/Circulatory static version printer friendly pdf version
Preventing Cardiovascular Events: Will HDL Therapeutics Change the Treatment Paradigm? static version printer friendly pdf version
Pulmonary Hypertension: New Potential in a Limited Market static version printer friendly pdf version


^ Top



R

Renin Inhibitors: A Novel Approach to Hypertension static version printer friendly pdf version
Reverse Heart Disease Now: Stop Deadly Cardiovascular Plaque Before Its Too Late static version printer friendly pdf version
Risk Stratification in the Diagnosis of Cardiovascular Disease static version printer friendly pdf version
rTPAs State-of-the-Science and Strategic Opportunities static version printer friendly pdf version


^ Top



S

Stakeholder Insight: Atherosclerosis - HDL, ApoA-I, Carotid MRI and 64-slice CT Offer Opportunities for Future Treatment static version printer friendly pdf version
Stakeholder Opinions: Heart Failure - When Drugs Do Not Work static version printer friendly pdf version
Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse Events With Drug-Eluting Stents Demand A New Safety Standard static version printer friendly pdf version
Strastegic Perspectives 2001: Diabetic Hypertension - Towards Aggressive, Individual and Holistic Treatment Strategies static version printer friendly pdf version
Strategic Perspectives 2001: Cardiovascular Gene Therapy - Injecting New Life Into Mature Markets static version printer friendly pdf version
Strategic Perspectives 2001: CV Major Players static version printer friendly pdf version
Strategic Perspectives: Marketed Antithrombotics - Plavix Adopts Lovenox's Developmental Defense Strategy static version printer friendly pdf version
Strategic Perspectives: Microvascular Complications in Diabetes static version printer friendly pdf version
Successful Management of Heart Failure Patients: Multidisciplinary Approach to Reducing Readmissions static version printer friendly pdf version


^ Top



T

Target Product Profiles 2008: Physician Insights on Key Attributes - Chronic Obstructive Pulmonary Disease static version printer friendly pdf version
Target Product Profiles 2008: Physician Insights on Key Attributes - Hypertension static version printer friendly pdf version
The Asian Cardiovascular Market Outlook to 2010 static version printer friendly pdf version
The Cardiovascular Market Outlook to 2008 static version printer friendly pdf version
The Cardiovascular Market Outlook to 2009 static version printer friendly pdf version
The Cardiovascular Market Outlook to 2010  static version printer friendly pdf version
The Cardiovascular Market Outlook to 2011 static version printer friendly pdf version
The Cardiovascular Outlook to 2007 static version printer friendly pdf version
The Eastern European Cardiovascular Market Outlook to 2010 static version printer friendly pdf version
The Latin American Cardiovascular Market Outlook to 2010 static version printer friendly pdf version
The Nuts and Bolts of Cardiac Pacing, 2nd Edition static version printer friendly pdf version
The Outlook for Cardiovascular Risk Factors: Epidemiology, market and pipeline analysis static version printer friendly pdf version
Thought Leader Insight & Analysis: Non-Interventional Cardiology static version printer friendly pdf version
Thrombolytics: State-of-the-Science and Strategic Opportunities static version printer friendly pdf version
Thrombosis in Cancer: A New Challenge For Low Molecular Weight Heparins static version printer friendly pdf version
Thrombosis: Growth opportunities for Antithrombotics and Thrombolytics  static version printer friendly pdf version
TPA in Stroke: Treatment Patterns and Potential static version printer friendly pdf version
Treatment Algorithms 2001: Stroke - Time is Brain static version printer friendly pdf version
Treatment Algorithms 2001: Venous Thromboembolism - Prophylaxis static version printer friendly pdf version
Treatment Algorithms 2002: Heart failure - managing chronic and acute patients static version printer friendly pdf version
Treatment Algorithms 2002: Venous Thromboembolism Acute Therapy static version printer friendly pdf version
Treatment of Elevated Cholesterol static version printer friendly pdf version


^ Top



U

U.S. Atrial Fibrillation Products Markets, 2005-2010 static version printer friendly pdf version
U.S. Coronary Stents Markets 2007 static version printer friendly pdf version
U.S. Pulmonary Arterial Hypertension Markets static version printer friendly pdf version
Update: The Cardiovascular Outlook 2000 static version printer friendly pdf version
US Markets for Interventional Cardiology Accessory Devices static version printer friendly pdf version


^ Top



V

Vascular Targeting Agents Current Status and Strategic Opportunities static version printer friendly pdf version
Vascular Targeting Agents: Emerging Competitors  static version printer friendly pdf version
Vytorin: Wave Two - Impact of ENHANCE Trial static version printer friendly pdf version


^ Top



W

Worldwide Heart Valve Market: Focus on Tissue Valves static version printer friendly pdf version
Worldwide PTCA Dollar Volume by Region, 2000-2004 static version printer friendly pdf version
Worldwide PTCA Procedures by Region, 2000-2004 static version printer friendly pdf version
Worldwide PTCA Unit Sales by Region, 2000-2004 static version printer friendly pdf version

All rights reserved. © copyright 2006 Research and Markets
Terms and conditions Privacy Policy